Back to Results
First PageMeta Content
HIV/AIDS / Entry inhibitors / Protease inhibitors / Carbamates / Antiretroviral drug / Vicriviroc / HIV / AIDS / Darunavir / Chemistry / Organic chemistry / Organofluorides


New Goals and New Drugs for People With Heavy Anti-HIV Drug Experience Writer: Mark Mascolini Editor: Jules Levin Medical Reviewer: Robert Heglar, MD,
Add to Reading List

Document Date: 2007-06-05 17:24:35

Open Document

File Size: 1,30 MB

Share Result on Facebook

City

Ft Lauderdale / Ingelheim / /

Company

ABC / Pfizer US / Viramune Nevirapine NVP Group / Genentech / Affect HIV / anti-HIV / United States (early 2007) Group / HIV / Merck / Schering-Plough / /

Country

United States / /

/

Event

FDA Phase / M&A / /

IndustryTerm

health food store / drug / HIV therapy / drug groups / Doctors / health insurance / /

MedicalCondition

another serious disease / HIV / headache / common cold / nausea / heart disease / diarrhea / severe liver disease / hepatitis / infections / cancers / AIDS disease / disease / AIDS diseases / vomiting / AIDS / dizziness / rash / /

MedicalTreatment

Salvage therapy / natural remedies / /

Organization

Food & Drug Administration / Federal Trade Commission / FDA / /

Person

Etravirine / /

/

Position

Drug Experience Writer / nurse / Mark Mascolini Editor / /

Product

Combivir / Efavirenz / Emtriva / CCR5 / Zidovudine / Videx / Aptivus / Agenerase / Trizivir / Norvir / CD4 / Retrovir / Sustiva / Rescriptor / Truvada / Epivir / omeprazole / Ziagen / Epzicom / Lexiva / Invirase / Crixivan / Fuzeon / Prezista / Viracept / Prilosec / Zerit / Nevirapine / Viramune / Abacavir / Lamivudine / Viread / Didanosine / Kaletra / Atripla / Reyataz / Stavudine / TMC114 / TNX-355 / one drug / /

ProvinceOrState

Florida / /

PublishedMedium

the United States Daily / /

URL

http /

SocialTag